{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:22:23Z","timestamp":1783189343779,"version":"3.54.6"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004726","name":"Ministry of Health, British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000233","name":"Genome British Columbia","doi-asserted-by":"publisher","award":["TIF001"],"award-info":[{"award-number":["TIF001"]}],"id":[{"id":"10.13039\/501100000233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003250","name":"Canadian Mental Health Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003250","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jad.2026.121910","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:22:12Z","timestamp":1777875732000},"page":"121910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacogenomic testing for major depressive disorder in British Columbia, Canada: Recommendations from a public deliberation"],"prefix":"10.1016","volume":"409","author":[{"given":"Louisa","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colene","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran C.","family":"O'Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Bunka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Pistawka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Riches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ridgway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Bousman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehannine","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stirling","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121910_bb0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/hex.12378","article-title":"Supporting quality public and patient engagement in health system organizations: development and usability testing of the Public and Patient Engagement Evaluation Tool","volume":"19","author":"Abelson","year":"2016","journal-title":"Health Expect."},{"key":"10.1016\/j.jad.2026.121910_bb0010","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1007\/BF03403702","article-title":"The embodiment of inequity: health disparities in Aboriginal Canada","volume":"96","author":"Adelson","year":"2005","journal-title":"Can. J. Public Health"},{"key":"10.1016\/j.jad.2026.121910_bb0015","author":"American Psychiatric Association"},{"key":"10.1016\/j.jad.2026.121910_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104965","article-title":"Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: systematic review and meta-analysis of randomised controlled trials","volume":"144","author":"Arnone","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2026.121910_bb0025","author":"BC Ministry of Health"},{"key":"10.1016\/j.jad.2026.121910_bb0030","author":"Bellamy"},{"key":"10.1016\/j.jad.2026.121910_bb0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cpt.2903","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants","volume":"114","author":"Bousman","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jad.2026.121910_bb0040","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cpt.2748","article-title":"Pharmacogenomic testing and depressive symptom remission: a systematic review and meta-analysis of prospective, controlled clinical trials","volume":"112","author":"Brown","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jad.2026.121910_bb0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/FPC.0000000000000579","article-title":"Pharmacogenetic testing coverage by Canadian insurance providers","volume":"36","author":"Brubaker-Plitt","year":"2026","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.jad.2026.121910_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115102","article-title":"Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: a rapid review and meta-analysis","volume":"321","author":"Bunka","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2026.121910_bb0055","author":"Canadian Institute for Health Information"},{"key":"10.1016\/j.jad.2026.121910_bb0060","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2026.121910_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/wps.20038","article-title":"The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons","volume":"12","author":"Cuijpers","year":"2013","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2026.121910_bb0070","first-page":"28","article-title":"Five Safes: designing data access for research","volume":"1601","author":"Desai","year":"2016"},{"key":"10.1016\/j.jad.2026.121910_bb0075","author":"Doctors of BC"},{"key":"10.1016\/j.jad.2026.121910_bb0080","author":"Doctors of BC"},{"key":"10.1016\/j.jad.2026.121910_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12687-020-00485-1","article-title":"Public engagement with genomic medicine: a summary of town hall discussions","volume":"12","author":"Etchegary","year":"2021","journal-title":"J. Community Genet."},{"key":"10.1016\/j.jad.2026.121910_bb0090","first-page":"1517","article-title":"Depression is the leading cause of disability around the world","volume":"317","author":"Friedrich","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2026.121910_bb0095","author":"Genome BC"},{"key":"10.1016\/j.jad.2026.121910_bb0100","doi-asserted-by":"crossref","first-page":"E1499","DOI":"10.1503\/cmaj.221785","article-title":"Cost-effectiveness of pharmacogenomic-guided treatment for major depression","volume":"195","author":"Ghanbarian","year":"2023","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.jad.2026.121910_bb0105","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/brainsci12070940","article-title":"Prognostic significance of blood-based baseline biomarkers in treatment-resistant depression: a literature review of available studies on treatment response","volume":"12","author":"Gkesoglou","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.jad.2026.121910_bb0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0032329206288152","article-title":"Deliberative impacts: the macro-political uptake of mini-publics","volume":"34","author":"Goodin","year":"2006","journal-title":"Polit. Soc."},{"key":"10.1016\/j.jad.2026.121910_bb0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10897-016-9987-0","article-title":"Effect of public deliberation on attitudes toward return of secondary results in genomic sequencing","volume":"26","author":"Gornick","year":"2017","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.jad.2026.121910_bb0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.sapharm.2009.08.002","article-title":"Consumers\u2019 views of pharmacogenetics\u2014a qualitative study","volume":"6","author":"Haddy","year":"2010","journal-title":"Res. Soc. Adm. Pharm."},{"key":"10.1016\/j.jad.2026.121910_bb0125","doi-asserted-by":"crossref","first-page":"E215","DOI":"10.9778\/cmajo.20200177","article-title":"Explaining the gaps in psychological distress and suicidal behaviours between non-indigenous and indigenous adults living off-reserve in Canada: a cross-sectional study","volume":"9","author":"Hajizadeh","year":"2021","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jad.2026.121910_bb0130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jac5.1868","article-title":"Establishing a patient-centered, multidisciplinary pharmacogenomics clinic in an academic health system: successes, challenges, and future direction","volume":"7","author":"Hoffecker","year":"2024","journal-title":"JACCP J. Am. Coll. Clin. Pharm."},{"key":"10.1016\/j.jad.2026.121910_bb0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1363461519861824","article-title":"The prevalence of distress, depression, anxiety, and substance use issues among indigenous post-secondary students in Canada","volume":"57","author":"Hop Wo","year":"2020","journal-title":"Transcult. Psychiatry"},{"key":"10.1016\/j.jad.2026.121910_bb0140","author":"Interior Health Data & Analytics Services"},{"key":"10.1016\/j.jad.2026.121910_bb0145","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41397-021-00249-1","article-title":"Economic evaluation in psychiatric pharmacogenomics: a systematic review","volume":"21","author":"Karamperis","year":"2021","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.jad.2026.121910_bb0150","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1089\/heq.2019.0041","article-title":"Social determinants of health inequities in Indigenous Canadians through a life course approach to colonialism and the residential school system","volume":"3","author":"Kim","year":"2019","journal-title":"Health Equity"},{"key":"10.1016\/j.jad.2026.121910_bb0155","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/07067437241245384","volume":"69","author":"Lam","year":"2024","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2026.121910_bb0160","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2217\/pgs-2016-0092","article-title":"Addressing ethical challenges at the intersection of pharmacogenomics and primary care using deliberative consultations","volume":"17","author":"Longo","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jad.2026.121910_bb0165","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0706743720904820","article-title":"Pharmacogenetic testing options relevant to psychiatry in Canada: options de tests pharmacog\u00e9n\u00e9tiques pertinents en psychiatrie au Canada","volume":"65","author":"Maruf","year":"2020","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2026.121910_bb0170","author":"Mayo Clinic"},{"key":"10.1016\/j.jad.2026.121910_bb0175","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/bcp.16058","article-title":"Public preferences for pharmacogenetic testing in the NHS: embedding a discrete choice experiment within service design to better meet user needs","volume":"90","author":"McDermott","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2026.121910_bb0180","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2013\/4985.3041","article-title":"Adverse drug reaction monitoring of antidepressants in the psychiatry outpatients department of a tertiary care teaching hospital","author":"Mishra","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.jad.2026.121910_bb0185","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/jopp.12028","article-title":"Deliberative voting: clarifying consent in a consensus process","volume":"22","author":"Moore","year":"2014","journal-title":"J. Polit. Philos."},{"key":"10.1016\/j.jad.2026.121910_bb0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000167801","article-title":"Engaging the public on biobanks: outcomes of the BC biobank deliberation","volume":"12","author":"O\u2019Doherty","year":"2009","journal-title":"Public Health Genomics"},{"key":"10.1016\/j.jad.2026.121910_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1526101","article-title":"Exploring perceived barriers and attitudes in young adults towards antidepressant pharmacotherapy, including the implementation of pharmacogenetic testing to optimize prescription practices","volume":"15","author":"Roberts","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2026.121910_bb0200","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/da.23135","article-title":"Treatment-resistant major depressive disorder: Canadian expert consensus on definition and assessment","volume":"38","author":"Rybak","year":"2021","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2026.121910_bb0205","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jnci\/djs649","article-title":"Enhancing citizen engagement in cancer screening through deliberative democracy","volume":"105","author":"Rychetnik","year":"2013","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.jad.2026.121910_bb0210","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jad.2024.09.041","article-title":"Drug metabolizing enzymes pharmacogenetic variation-informed antidepressant therapy approach for common mental disorders: a systematic review and meta-analysis","volume":"367","author":"Santenna","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121910_bb0215","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/0272989X21998980","article-title":"Layperson views about the design and evaluation of decision aids: a public deliberation","volume":"41","author":"Schwartz","year":"2021","journal-title":"Med. Decis. Mak. Int. J. Soc. Med. Decis. Mak."},{"key":"10.1016\/j.jad.2026.121910_bb0220","author":"Sheedy"},{"key":"10.1016\/j.jad.2026.121910_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105009","article-title":"Clinical implementation of preemptive pharmacogenomics in psychiatry","volume":"101","author":"Skokou","year":"2024","journal-title":"eBioMedicine"},{"key":"10.1016\/j.jad.2026.121910_bb0230","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/07067437221140383","article-title":"Pharmacogenomic testing for major depression: a qualitative study of the perceptions of people with lived experience and professional stakeholders","volume":"68","author":"Slomp","year":"2023","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2026.121910_bb0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hast.27","article-title":"Why and when should we use public deliberation?","volume":"42","author":"Solomon","year":"2012","journal-title":"Hast. Cent. Rep."},{"key":"10.1016\/j.jad.2026.121910_bb0240","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.biopsych.2012.10.030","article-title":"Contribution of common genetic variants to antidepressant response","volume":"73","author":"Tansey","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121910_bb0245","article-title":"Sharing linked data sets for research: results from a deliberative public engagement event in British Columbia, Canada","volume":"4","author":"Teng","year":"2019","journal-title":"Int. J. Popul. Data Sci."},{"key":"10.1016\/j.jad.2026.121910_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1276410","article-title":"Efficacy and safety of pharmacogenomic-guided antidepressant prescribing in patients with depression: an umbrella review and updated meta-analysis","volume":"15","author":"Tesfamicael","year":"2024","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2026.121910_bb0255","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1186\/s12888-020-02919-z","article-title":"Primary care and mental health providers\u2019 perceptions of implementation of pharmacogenetics testing for depression prescribing","volume":"20","author":"Vest","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2026.121910_bb0260","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ps.20240080","article-title":"The perceived value of pharmacogenetic testing in depression treatment: mixed-methods results from the PRIME Care Study","author":"Vest","year":"2025","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2026.121910_bb0265","author":"World Health Organization"},{"key":"10.1016\/j.jad.2026.121910_bb0270","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/jpm12101615","article-title":"Public attitudes toward pharmacogenomic testing and establishing a statewide pharmacogenomics database in the State of Minnesota","volume":"12","author":"Zhang","year":"2022","journal-title":"J. Pers. Med."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726007627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726007627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:03:54Z","timestamp":1783188234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726007627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"alternative-id":["S0165032726007627"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121910","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacogenomic testing for major depressive disorder in British Columbia, Canada: Recommendations from a public deliberation","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121910"}}